Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Membranous lupus nephropathy: a clinicopathologic study

J V Donadio, J H Burgess, K E Holley

    Medicine
    |November 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Case of Frequent Uterine Hemorrhagy, with Incessant Discharge of the Liquor Amnii, Four Months Previous to Labour; with Some Remarks on the Ergot of Rye.

    The London medical and physical journal·2018
    Same author

    Role of dietary fish oil supplementation in IgA nephropathy. Mechanistic implications.

    Minerva urologica e nefrologica = The Italian journal of urology and nephrology·2001
    Same author

    n-3 Fatty acids and their role in nephrologic practice.

    Current opinion in nephrology and hypertension·2001
    Same author

    The emerging role of omega-3 polyunsaturated fatty acids in the management of patients with IgA nephropathy.

    Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation·2001
    Same author

    Suppressive effects of fish oil on mesangial cell proliferation in vitro and in vivo.

    Kidney international·2000
    Same author

    Use of fish oil to treat patients with immunoglobulin a nephropathy.

    The American journal of clinical nutrition·2000

    Membranous lupus nephropathy in systemic lupus erythematosus (SLE) patients often presents with stable renal function and proteinuria. Prednisone treatment showed no impact on outcomes, suggesting a distinct renal pathogenesis.

    Area of Science:

    • Nephrology
    • Rheumatology
    • Immunology

    Background:

    • Systemic lupus erythematosus (SLE) can affect the kidneys, with membranous lupus nephropathy being a distinct morphologic lesion.
    • Understanding the natural history and treatment response of membranous lupus nephropathy in SLE is crucial for patient management.

    Purpose of the Study:

    • To investigate the long-term renal course and outcomes of patients with SLE and membranous lupus nephropathy.
    • To assess the impact of prednisone treatment on proteinuria and renal function in this patient cohort.

    Main Methods:

    • A longitudinal follow-up study of 28 patients with SLE and biopsy-proven membranous lupus nephropathy over 4 years.
    • Clinical data collection including systemic SLE features, serologic markers (LE cell tests, ANA, complement, anti-native DNA), proteinuria, hematuria, renal function, and treatment response.

    Related Experiment Videos

    Main Results:

    • Membranous lupus nephropathy represented approximately 8% of SLE patients evaluated over 12 years.
    • Patients exhibited typical SLE features; proteinuria and hematuria often appeared years after systemic symptoms.
    • Only two patients developed slowly progressive renal failure; most maintained proteinuria. Prednisone did not alter proteinuria or renal function. Cardiovascular disease was the primary cause of mortality (21%).

    Conclusions:

    • Membranous lupus nephropathy in SLE patients typically follows a relatively benign and stable renal course.
    • The distinct renal pathogenesis of membranous lupus nephropathy may differ from proliferative lupus nephritis.
    • Further research into the specific mechanisms driving membranous lupus nephropathy in SLE is warranted.